15th International Congress on Myeloproliferative Neoplasms
The 15th International Congress on Myeloproliferative Neoplasms (MPNs), held November 2-3, 2023 in Brooklyn, New York, featured a range of topics, including the latest in clinical trials, analysis of the impact of driver mutations in MPNs, and more.
Advertisement
Advertisement
Primary myelofibrosis developed secondary neoplasms earlier and at higher rates versus other myeloproliferative neoplasms.
Essential thrombocythemia with CALR mutations had a higher risk of progression to myelofibrosis compared with JAK2 mutations.
A deep learning-based pathomics approach had potential in estimating bone marrow cellularity in patients with MPNs.
MPNs were not the primary cause of strokes in veterans, though researchers found they were strongly associated.
Patients with polycythemia vera developed secondary malignancies at a higher rate versus other myeloproliferative neoplasms.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.